CBTR OPTICAL LABS LLC
7330 EASTGATE RD STE 130, HENDERSON, NV 89011
NPI Number
1417436775
Practice location · View on Google Maps
SOS Verification: Pending Review
Multiple SOS Matches
Total Medicaid Payments
$2,109,833
+463% vs specialty average
Patients Seen
336,809
Total Claims
381,833
$ Per Patient
$6
Specialty avg: $11
Specialty Rank
#1 of 13
Technician/Technologist, Optician providers in Nevada
Peer Average
$374,468
Average total for Technician/Technologist, Optician
Claims per Patient
1.1
Average visits / services per person
Payments by Year
How much Medicaid paid this provider each year. Large jumps can indicate changes in practice volume or billing patterns.
| Year | Total Paid | % of Max |
|---|---|---|
| 2021 | $382,038 | |
| 2022 | $642,489 | |
| 2023 | $678,750 | |
| 2024 | $406,555 |
Procedure Code Breakdown
The specific medical services this provider billed Medicaid for. Each HCPCS/CPT code represents a different type of visit, test, or treatment.
| HCPCS Code | Description | Claims | Paid | % of Total | Avg per Claim |
|---|---|---|---|---|---|
| V2103 | Spherocylinder, single vision, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens | 65,874 | $642,069 | 30.4% | $10 |
| V2020 | Frames, purchases | 107,414 | $510,966 | 24.2% | $5 |
| V2100 | Sphere, single vision, plano to plus or minus 4.00, per lens | 23,778 | $205,084 | 9.7% | $9 |
| A9901 | Medical equipment delivery, set up, and/or dispensing service component of another procedure code code | 71,676 | $189,024 | 9.0% | $3 |
| V2104 | Spherocylinder, single vision, plano to plus or minus 4.00d sphere, 2.12 to 4.00d cylinder, per lens | 14,393 | $121,909 | 5.8% | $8 |
| V2797 | Vision supply, accessory and/or service component of another procedure code vision code | 37,646 | $110,796 | 5.3% | $3 |
| V2203 | Spherocylinder, bifocal, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens | 8,083 | $94,843 | 4.5% | $12 |
| V2107 | Spherocylinder, single vision, plus or minus 4.25 to plus or minus 7.00 sphere, .12 to 2.00d cylinder, per lens | 8,392 | $72,270 | 3.4% | $9 |
| V2784 | Lens, polycarbonate or equal, any index, per lens | 29,842 | $47,015 | 2.2% | $2 |
| V2105 | Spherocylinder, single vision, plano to plus or minus 4.00d sphere, 4.25 to 6.00d cylinder, per lens | 3,041 | $24,570 | 1.2% | $8 |
| V2200 | Sphere, bifocal, plano to plus or minus 4.00d, per lens | 2,586 | $24,563 | 1.2% | $9 |
| V2108 | Spherocylinder, single vision, plus or minus 4.25d to plus or minus 7.00d sphere, 2.12 to 4.00d cylinder, per lens | 2,539 | $20,082 | 1.0% | $8 |
| V2101 | Sphere, single vision, plus or minus 4.12 to plus or minus 7.00d, per lens | 1,987 | $15,462 | 0.7% | $8 |
| V2111 | Spherocylinder, single vision, plus or minus 7.25 to plus or minus 12.00d sphere, .25 to 2.25d cylinder, per lens | 1,301 | $10,714 | 0.5% | $8 |
| V2204 | Spherocylinder, bifocal, plano to plus or minus 4.00d sphere, 2.12 to 4.00d cylinder, per lens | 690 | $6,433 | 0.3% | $9 |
| V2207 | Spherocylinder, bifocal, plus or minus 4.25 to plus or minus 7.00d sphere,.12 to 2.00d cylinder, per lens | 457 | $4,641 | 0.2% | $10 |
| V2112 | Spherocylinder, single vision, plus or minus 7.25 to plus or minus 12.00d sphere, 2.25d to 4.00d cylinder, per lens | 464 | $3,576 | 0.2% | $8 |
| V2109 | Spherocylinder, single vision, plus or minus 4.25 to plus or minus 7.00d sphere, 4.25 to 6.00d cylinder, per lens | 376 | $2,970 | 0.1% | $8 |
| V2025 | Deluxe frame | 1,240 | $2,517 | 0.1% | $2 |
| V2102 | Sphere, single vision, plus or minus 7.12 to plus or minus 20.00d, per lens | 26 | $216 | 0.0% | $8 |
| V2114 | Spherocylinder, single vision, sphere over plus or minus 12.00d, per lens | 13 | $114 | 0.0% | $9 |
| V2760 | Scratch resistant coating, per lens | 15 | $0 | 0.0% | $0 |
About This Data
This data comes from the HHS Medicaid Provider Spending dataset (opendata.hhs.gov). It shows payments made through Nevada Medicaid from 2018–2024. High payments do not mean a provider is doing anything wrong — some specialties naturally cost more, and busy providers see more patients. But unusually high numbers compared to peers can be worth a closer look.